Genzyme Corp made its case for why it is worth more than the $18.5 billion being offered by France’s Sanofi-Aventis, forecasting peak sales for its experimental multiple sclerosis drug Campath and 2011 profit well above Wall Street estimates.
View full post on All News, Video and Posts related to SECTOR: Health Care
Popular Posts:
- GlaxoSmithKline Fined $3 Billion In Fraud Case
- GlaxoSmithKline Fined $3 Billion In Fraud Case
- Smead Products – Smead – Antimicrobial Two-Pocket Portfolio, Embossed Leather Grain 11-Pt Stock, Blue – Sold As 1 Box – Treated with nontoxic SilverCoTM to fight the growth of bacteria, mold, fungus and mildew. – Acid-free, archival quality makes it safe for long-term storage of documents, records, photos. – Keeps hard copy, media and contact information together. – Ideal for offices and healthcare facilities. -
- Healthcare Ethics and Human Values: An Introductory Text with Readings and Case Studies
- How do you feel about the healthcare law that makes parents keep their children on their health insurance?